All 101 IBRN (ISHARES NEUROSCIENCE AND HEALTHCARE ETF) Holdings
There are 101 IBRN holdings. Top 10 companies weight: 40.18%.
Total Market Cap: $223B
Rank | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Average | (101 stocks) | +1.01% | 21.04 | 25.59 | 0.29 | +35.38% | +9.56% | 0.82 | ||||||||||
1 | XENE | Xenon Pharmaceuticals Inc | 5.17% | $66.04 | $6.54B | Biotechnology | Healthcare | +40.27% | N/A | N/A | N/A | N/A | N/A | 78 | +21.99% | $81 | +29.09% | 0.92 |
2 | PTCT | Ptc Therapeutics Inc | 4.21% | $78.01 | $6.53B | Biotechnology | Healthcare | -16.59% | N/A | 56.82 | 0.81 | N/A | N/A | 75 | +22.97% | $96 | +12.92% | 0.99 |
3 | BIIB | Biogen Inc | 3.96% | $199.95 | $29B | Drug Manufacturers - General | Healthcare | -15.32% | 17.41 | 14.75 | 0.64 | N/A | N/A | 65 | +13.17% | $226 | -9.14% | 0.51 |
4 | NBIX | Neurocrine Biosciences Inc | 3.95% | $173 | $17B | Drug Manufacturers - Specialty & Generic | Healthcare | +9.25% | 25.72 | 24.10 | 0.21 | N/A | N/A | 75 | +15.75% | $200 | +12.11% | 0.79 |
5 | ALKS | Alkermes Plc | 3.86% | $51.72 | $8.65B | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | 56.04 | 136.99 | 1.96 | N/A | N/A | N/A | N/A | N/A | +16.50% | N/A |
6 | AXSM | Axsome Therapeutics Inc | 3.85% | $221.64 | $12B | Biotechnology | Healthcare | +6.89% | N/A | 333.33 | N/A | N/A | N/A | 77 | +26.51% | $280 | +31.16% | 0.66 |
7 | SRRK | Scholar Rock Holding Corp | 3.84% | $50.66 | $6.44B | Biotechnology | Healthcare | +5.29% | N/A | N/A | N/A | N/A | N/A | 79 | +17.07% | $59 | +9.02% | 0.67 |
8 | ACAD | Acadia Pharmaceuticals Inc | 3.78% | $25.09 | $4.43B | Biotechnology | Healthcare | N/A | 11.73 | 76.34 | 0.19 | N/A | N/A | 72 | +30.13% | $33 | +1.12% | 0.90 |
9 | ARGX | Argenx Se Adr | 3.78% | $846.19 | $57B | Biotechnology | Healthcare | N/A | 24.30 | 32.89 | 0.21 | N/A | N/A | 79 | +24.69% | $1.06K | +21.54% | 0.46 |
10 | ARWR | Arrowhead Pharmaceuticals Inc | 3.78% | $71.65 | $10B | Biotechnology | Healthcare | +15.23% | N/A | 111.11 | N/A | N/A | N/A | 78 | +33.98% | $96 | +1.03% | 1.63 |
11 | PRAX | N/A | 3.77% | $304.43 | $8.87B | Biotechnology | Healthcare | -18.18% | N/A | N/A | N/A | N/A | N/A | 75 | +100.39% | $610 | +3.11% | 0.93 |
12 | DNLI | Denali Therapeutics Inc | 3.55% | $22.90 | $3.65B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +49.56% | $34 | -18.93% | 1.45 |
13 | DNTH | Dianthus Therapeutics Inc | 3.40% | $101 | $5.45B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +27.31% | $129 | 0.00% | 1.11 |
14 | SUPN | Supernus Pharmaceuticals Inc | 3.19% | $47.42 | $2.77B | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | N/A | 20.16 | 1.47 | N/A | N/A | 75 | +33.91% | $64 | +11.35% | 0.49 |
15 | CPRX | Catalyst Pharmaceuticals Inc | 3.05% | $31.49 | $3.85B | Biotechnology | Healthcare | +20.98% | 17.44 | 12.95 | 1.73 | N/A | N/A | 54 | +0.57% | $32 | +40.70% | 0.87 |
16 | CNTA | Centessa Pharmaceuticals Plc Adr | 2.91% | $40.50 | $6.27B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | +14.05% | N/A |
17 | EWTX | Edgewise Therapeutics Inc | 2.72% | $38.81 | $4.39B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +28.63% | $50 | +13.70% | 1.37 |
18 | DYN | Dyne Therapeutics Inc Ordinary Shares | 2.69% | $23.45 | $3.96B | Biotechnology | Healthcare | N/A | N/A | N/A | 0.19 | N/A | N/A | 76 | +67.16% | $39 | +3.77% | 1.77 |
19 | SRPT | Sarepta Therapeutics Inc | 2.10% | $16.83 | $1.86B | Biotechnology | Healthcare | N/A | 4.88 | 5.01 | 159.25 | N/A | N/A | 48 | +31.73% | $22 | -24.47% | 1.40 |
20 | n/a | N/A | 2.01% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
21 | AXGN | Axogen Inc | 1.92% | $39.48 | $2.06B | Medical Devices | Healthcare | +2.38% | N/A | 344.83 | N/A | N/A | N/A | 80 | +28.62% | $51 | +14.38% | 0.89 |
22 | n/a | H. Lundbeck As Ordinary Shares Class B | 1.85% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
23 | CAPR | Capricor Therapeutics Inc | 1.75% | $19.50 | $1.17B | Biotechnology | Healthcare | +22.65% | N/A | 78.74 | N/A | N/A | N/A | 80 | +174.87% | $54 | +31.39% | 1.45 |
24 | n/a | Bioarctic Ab Class B | 1.46% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
25 | BHVN | Biohaven Ltd | 1.32% | $14.84 | $2.24B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 71 | +53.30% | $23 | 0.00% | 1.45 |
26 | TSHA | N/A | 1.21% | $5.58 | $1.78B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 80 | +132.97% | $13 | -22.80% | 1.42 |
27 | n/a | Neuren Pharmaceuticals Ltd | 1.04% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
28 | n/a | Dynavox Group Ab | 1.01% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
29 | RAPP | Rapport Therapeutics Inc | 0.97% | $40.21 | $1.91B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 77 | +40.86% | $57 | 0.00% | 1.26 |
30 | n/a | Idorsia Ltd | 0.84% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
31 | DRUG | N/A | 0.84% | $74.61 | $728M | Biotechnology | Healthcare | +8.42% | N/A | N/A | N/A | N/A | N/A | 78 | +124.51% | $168 | +28.14% | N/A |
32 | ANNX | Annexon Inc Ordinary Shares | 0.82% | $5.57 | $1.26B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 77 | +167.15% | $15 | -24.53% | 1.23 |
33 | n/a | Sanbio Co Ltd | 0.80% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
34 | IART | Integra Lifesciences Holdings Corp | 0.75% | $18.89 | $1.45B | Medical Devices | Healthcare | N/A | N/A | 7.82 | N/A | N/A | N/A | 50 | -1.43% | $19 | -22.63% | 1.33 |
35 | ANRO | Alto Neuroscience Inc | 0.68% | $25.97 | $973M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 72 | +35.27% | $35 | 0.00% | 1.26 |
36 | n/a | Medincell Sa | 0.62% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
37 | n/a | Chf/usd Purchased | 0.59% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
38 | n/a | Sek/usd Purchased | 0.58% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
39 | n/a | Sek Cash | 0.55% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
40 | BWAY | Brainsway Ltd Adr | 0.55% | $16.50 | $440M | Medical Devices | Healthcare | N/A | 79.88 | 37.45 | 0.36 | N/A | N/A | 75 | +6.06% | $18 | +29.11% | 1.13 |
41 | CBLL | Ceribell Inc | 0.55% | $18.43 | $734M | Medical Devices | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 78 | +45.74% | $27 | 0.00% | 1.51 |
42 | n/a | N/A | 0.54% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
43 | LBRX | Lb Pharmaceuticals Inc | 0.53% | $30.90 | $922M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 79 | +45.63% | $45 | 0.00% | 0.58 |
44 | n/a | Microport Neuroscientific Corp | 0.51% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
45 | SLDB | Solid Biosciences Inc | 0.51% | $8.45 | $947M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 82 | +107.10% | $18 | -28.67% | 1.77 |
46 | AVXL | Anavex Life Sciences Corp | 0.47% | $2.42 | $232M | Biotechnology | Healthcare | +0.72% | N/A | 3.85 | N/A | N/A | N/A | 75 | +726.45% | $20 | -36.07% | 1.35 |
47 | PRTA | Prothena Corp Plc | 0.46% | $8.67 | $447M | Biotechnology | Healthcare | -1.54% | N/A | 10.63 | N/A | N/A | N/A | N/A | +146.83% | $21 | -30.09% | 0.89 |
48 | RGNX | Regenxbio Inc | 0.46% | $10.32 | $633M | Biotechnology | Healthcare | +13.05% | N/A | N/A | N/A | N/A | N/A | 81 | +135.17% | $24 | -22.82% | 1.83 |
49 | VNDA | Vanda Pharmaceuticals Inc | 0.45% | $5.32 | $352M | Biotechnology | Healthcare | N/A | N/A | 103.09 | N/A | N/A | N/A | 68 | +165.41% | $14 | -22.64% | 0.64 |
50 | BNTC | Benitec Biopharma Inc | 0.43% | $11.97 | $447M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 79 | +115.54% | $26 | -28.81% | 0.76 |
IBRN (ISHARES NEUROSCIENCE AND HEALTHCARE ETF) Sector Allocation
HEALTHCARE
77.80%MATERIALS
1.00%INFORMATION TECHNOLOGY
0.00%COMMUNICATION SERVICES
0.00%CONSUMER DISCRETIONARY
0.00%CONSUMER STAPLES
0.00%INDUSTRIALS
0.00%UTILITIES
0.00%ENERGY
0.00%FINANCIALS
0.00%REAL ESTATE
0.00%